Altoona Arthritis & Ostprss Duncansville, PA - 16635

Altoona Arthritis & Ostprss is categorized under Physicians Offices in Duncansville, PA and active since 1982.

Altoona Arthritis & Ostprss was established in 1982, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Alan J Kivitz at the company’s single location by writing to 175 Meadowbrook Lane, Duncansville, Pennsylvania PA 16635 or by phoning (800) 924-7790. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Altoona Arthritis & Ostprss
Contact Person: Alan J Kivitz
Address: 175 Meadowbrook Lane, Duncansville, Pennsylvania 16635
Phone Number: (800) 924-7790
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1982
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians Offices
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Altoona Arthritis & Ostprss was started in 1982 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Alan J Kivitz for inquiries that concern Altoona Arthritis & Ostprss by calling the company number (800) 924-7790, as your correspondence is most welcome. Additionally, the physical location of the single location of Altoona Arthritis & Ostprss can be found at the coordinates 40.40492,-78.43603 as well as the street address 175 Meadowbrook Lane in Duncansville, Pennsylvania 16635.

For its online presence, you may visit Altoona Arthritis & Ostprss’s website at and engage with its social media outlets through on Twitter and on Facebook.